Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 4

The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease

Authors Hooper C, Calvert J, Chisholm A

Published 5 December 2008 Volume 2008:3(4) Pages 659—669


Review by Single-blind

Peer reviewer comments 4

C Hooper, J Calvert

North Bristol Lung Centre, Southmead Hospital, Bristol, UK

Abstract: Prescription of mucoactive drugs for chronic obstructive pulmonary disease (COPD) is increasing. This development in clinical practice arises, at least in part, from a growing understanding of the important role that exacerbation frequency, systemic inflammation and oxidative stress play in the pathogenesis of respiratory disease. S-carboxymethylcysteine (carbocisteine) is the most frequently prescribed mucoactive agent for long-term COPD use in the UK. In addition to its mucoregulatory activity, carbocisteine exhibits free-radical scavenging and anti-inflammatory properties. These characteristics have stimulated interest in the potential that this and other mucoactive drugs may offer for modification of the disease processes present in COPD. This article reviews the pharmacology, in vivo and in vitro properties, and clinical trial evidence for carbocisteine in the context of guidelines for its use and the current understanding of the pathogenic processes that underlie COPD.

Keywords: carbocisteine, chronic obstructive pulmonary disease (COPD), exacerbation, free radicals, inflammation, mucolytic, oxidative stress, S-carboxymethylcysteine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]